Relative to other tumor-infiltrating T cells, CD103+ TRM also displayed upregulation of immune checkpoint receptors such as PD-1, LAG-3, CTLA-4 and TIM-3 (Figure 1B) [20,88,90,133]. This evidence concerns the gene ITGAE and neoplasm.